Skip to main content
Skip to content
Case File
d-32019House OversightOther

Biographical overview of Rep. Diana DeGette’s legislative priorities

The document is a promotional biography praising Rep. DeGette’s policy work with no specific allegations, financial transactions, or controversial actions. It offers no actionable leads for investigat Rep. Diana DeGette serves her 8th term from Colorado’s 1st District. Member of the House Energy and Commerce Committee. Advocated for SCHIP expansion, stem‑cell research legislation, and diabetes car

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #031184
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The document is a promotional biography praising Rep. DeGette’s policy work with no specific allegations, financial transactions, or controversial actions. It offers no actionable leads for investigat Rep. Diana DeGette serves her 8th term from Colorado’s 1st District. Member of the House Energy and Commerce Committee. Advocated for SCHIP expansion, stem‑cell research legislation, and diabetes car

Tags

biographyhealth-policyhouse-oversightenergy-and-commercelegislation

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
Chief Deputy Whip Diana DeGette is serving her 8th term in Congress as the Representative of the First District in Colorado. Diana has established herself as a leader for progressive change on LGBT rights, health care, reproductive rights, food safety, consumer protection and the environment. Diana serves on the powerful Commuttee on Energy and Commerce where she has used her position to improve health care, expand medical research, reform corporate business and accounting practices, ensure that our homeland is adequately protected, take on global climate change, and move America toward energy independence. She has led the efforts to expand the State Children's Health Insurance Program (SCHIP), which provides health insurance to low-income children up to age 18. Diana was a leader in the expansion of this program that was signed into law by President Obama in February of 2009. Diana was the chief architect of legislation to expand stem cell research, which was passed twice with broad, bipartisan support in Congress. One of Congress’s leading experts on cutting-edge scientific research, Diana ts the author of the Stem Cell Research Enhancement Act which would ensure a lasting ethical framework overseeing stem cell research at the National Institutes of Health (NIA) and will provide stability to the scientists and individuals who are on the quest for life-saving cures. As co-chair of the bipartisan Congressional Diabetes Caucus, Diana has also been a long-time advocate for the expansion of diabetes care and research, particularly for lower-income and munority communities. Approved by Diana DeGette for Congress Come and Join Congresswoman Diana DeGette in New York City September 27”, 2012 “Sccence’s Voice in Congress”

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.